Quick Answer
Korro Bio, Inc. reported Net Income of -$117.26 million for fiscal year 2025.
Korro Bio, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$117.26M | -40.3% |
| 2024 | -$83.58M | -3.0% |
| 2023 | -$81.17M | -39.9% |
| 2022 | -$58.03M | +31.5% |
| 2021 | -$84.69M | -219.4% |
| 2020 | -$26.51M | -41.4% |
| 2019 | -$18.75M | +2.2% |
| 2018 | -$19.17M | +5.3% |
| 2017 | -$20.24M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$18.06M | +14.0% | +29.9% |
| June 30, 2025 | -$25.77M | -18.1% | -10.2% |
| March 31, 2025 | -$23.39M | -19.6% | -11.4% |
| September 30, 2024 | -$21.00M | -13.6% | +3.8% |
| June 30, 2024 | -$21.83M | -23.7% | -11.6% |
| March 31, 2024 | -$19.56M | +0.2% | -5.8% |
| September 30, 2023 | -$18.49M | +5.4% | -4.8% |
| June 30, 2023 | -$17.65M | +17.1% | +10.0% |
- Korro Bio, Inc. showed a decrease of -40.3% in Net Income compared to the prior fiscal year.
- Over the 2017–2025 period, Korro Bio, Inc.’s net income has declined by 479.4% (from -$20.24 million to -$117.26 million).
- The most recent figure is from Korro Bio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: